Pathogen Disease Sample Prep Firm NanoMR Raises $13M in Series B

The company has developed immunomagnetic technology that, when coupled with molecular diagnostic methods, such as PCR or DNA hybridization, can identify infectious organisms in less than two hours.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.